Etiopathogenesis of catatonia: Generalizations and working hypotheses

Journal of ECT

Volumn 26, Issue 4, 2010, Pages 253-258

  Dhossche, Dirk M ^a   Stoppelbein, Laura ^a   Rout, Ujjwal K ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

autoimmune encephalitis; benzodiazepines; catatonia; ECT; endocrine; epilepsy; etiology; genetic; immune; Kleine Levin syndrome; motor circuitry; neuroleptic malignant syndrome; neurotransmitter; pathophysiology; Prader Willi syndrome

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ANTICONVULSIVE AGENT; BENZODIAZEPINE; DOPAMINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; NEUROTRANSMITTER;

AUTONOMIC DYSFUNCTION; CATATONIA; DISEASE ASSOCIATION; DRUG MEGADOSE; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; ENCEPHALITIS; ENDOCRINE DISEASE; EPIDEMIC ENCEPHALITIS; EPILEPSY; GENETIC PREDISPOSITION; GENETIC RISK; HYPERSOMNIA; HYPOPARATHYROIDISM; HYPOTHALAMUS; IMMUNE DEFICIENCY; MOTOR DYSFUNCTION; MOTOR NERVE; NERVE CONDUCTION; NEUROENDOCRINE DISEASE; NEUROLEPTIC MALIGNANT SYNDROME; NEUROTRANSMITTER RELEASE; NEUROTRANSMITTER UPTAKE; NONHUMAN; PHEOCHROMOCYTOMA; PRADER WILLI SYNDROME; REVIEW; THYROTOXICOSIS;

CATATONIA; EFFERENT PATHWAYS; ENDOCRINE GLANDS; EPILEPSY; HUMANS; IMMUNE SYSTEM DISEASES; NEUROTRANSMITTER AGENTS;

EID: 78650485010     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3181fbf96d     Document Type: Review

References (124)

1. Kahlbaum K. Die Katatonie oder das Spannungsirresein. Berlin, Germany: Verlag August Hirshwald; 1874.
2. Kraepelin E. Psychiatrie: Ein Lehrbuch fur Studirende und Aerzte. 5th ed. Leipzig, Germany: Barth; 1896.
3. Abrams R, Taylor M. Catatonia: a prospective clinical study. Arch Gen Psychiatry. 1976;33:579-581.
4. Morrison J. Catatonia: retarded and excited types. Arch Gen Psychiatry. 1973;28:39-41.
5. Gelenberg A. The catatonic syndrome. Lancet. 1976;1:1339-1341.
6. Taylor M, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry. 2003;160:1-9.
7. Bush G, Fink M, Petrides G, et al. Catatonia: I: rating scale and standardized examination. Acta Psychiatr Scand. 1996;93:129-136.
8. Fink M, Taylor M. Catatonia. A Clinician's Guide to Diagnosis and Treatment. Cambridge: University Press; 2003.
9. Caroff S, Mann S, Francis A, et al. Catatonia. From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Publishing, Inc; 2004.
10. Northoff G, Eckert J, Fritze J. Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. J Neurol Neurosurg Psychiatry. 1997;62:404-406.
11. Thomas C, Carroll BT, Maley RT, et al. Memantine and catatonic schizophrenia. Am J Psychiatry. 2005;162:626.
12. Van der Heijden F, Tuinier S, Arts N, et al. Catatonia: disappeared or under-diagnosed? Psychopathol. 2005;15:3-8.
13. Stauder K. Die todliche Katatonie. Arch Psychiatr Nervenkrank. 1934;102:614-634.
14. Fink M, Taylor M. Neuroleptic malignant syndrome is malignant catatonia, warranting treatments efficacious for catatonia. Progr Neuropsychopharmacol Biol Psychiatry. 2006;30:1182-1183.
15. Cohen D, Flament M, Dubos P-F, et al. Case series: catatonic syndrome in young people. J Am Acad Child Adolesc Psychiatry. 1999;38:1040-1046.
16. Dhossche D. Catatonia in autistic disorders [brief report]. J Autism Dev Disord. 1998;28:329-331.
17. Dhossche D, Bouman N. Catatonia in an adolescent with Prader-Willi syndrome. Ann Clin Psychiatry. 1997;4:247-253.
18. Dhossche D, Bouman N. Catatonia in children and adolescents [letter]. J Am Acad Child Adolesc Psychiatry. 1997;36:870-871.
19. Dhossche D, Shettar S, Kumar T, et al. Electroconvulsive therapy for malignant catatonia in adolescence. South Med J. 2009;102:1170-1172.
20. Rosebush P, MacQueen G, Clarke J, et al. Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues. J Clin Psychiatry. 1995;58:347-353.
21. Takaoka K, Takaoka T. Catatonia in childhood and adolescence. Psychiatry Clin Neurosci. 2003;57:129-137.
22. Zaw F, Bates G, Murali V, et al. Catatonia, autism, and ECT. Dev Med Child Neurol. 1999;41:843-845.
23. Dhossche D, Cohen D, Ghaziuddin N, et al. The study of pediatric catatonia supports a home of its own for catatonia in DSM-5. Med Hypotheses. 2010 August 9. [Epub ahead of print].
24. Dhossche D, Wilson C, Wachtel L. Catatonia in childhood and adolescence: implications for the DSM-5. Prim Psychiatry. 2010;17:35-39.
25. Northoff G. Neuroimaging and neurophysiology. In: Caroff S, Mann S, Francis A, et al, eds. Catatonia. From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Publishing; 2004.
26. Mann S, Caroff S, Fricchione G, et al. Malignant catatonia. In: Caroff S, Mann S, Francis A, et al, eds. Catatonia. From Psychopathology to Neurobiology. Washington, DC, and London, UK: American Psychiatric Publishing, Inc; 2004:105-119.
27. Stoppelbein L, Greening L, Kakooza A. The importance of catatonia and stereotypies in autistic spectrum disorders. Int Rev Neurobiol. 2006;72:103-118.
28. Dhossche D, Reti I, Shettar S, et al. Tics as signs of catatonia. Electroconvulsive therapy response in two men. J ECT. 2010;26:266-269.
29. Lewis MH, Tanimura Y, Lee LW, et al. Animal models of restricted repetitive behavior in autism. Behav Brain Res. 2007;176:66-74.
30. Mandy WP, Skuse DH. Research review: what is the association between the social-communication element of autism and repetitive interests, behaviours and activities? J Child Psychol Psychiatry. 2008;49:795-808.
31. Singer HS. Motor stereotypies. Semin Pediatr Neurol. 2009;16:77-81.
32. Carroll B. The universal field hypothesis of catatonia and neuroleptic malignant syndrome. CNS Spectrums. 2000;5:26-33.
33. Fricchione GL. Neuroleptic catatonia and its relationship to psychogenic catatonia. Biol Psychiatry. 1985;20:304-313.
34. Northoff G, Lins H, Boker H, et al. Therapeutic efficacy of N-methyl D-aspartate antagonist amantadine in febrile catatonia. J Clin Psychopharmacol. 1999;19:484-486.
35. Northoff G, Demisch L, Wenke J, et al. Plasma homovanillic acid concentrations in catatonia. Biol Psychiatry. 1996;39:436-443.
36. Northoff G, Wenke J, Demisch L, et al. Catatonia: short-term response to lorazepam and dopaminergic metabolism. Psychopharmacol. 1995;122:182-186.
37. Fricchione G, Cassem N, Hooberman D, et al. Intravenous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharmacol. 1983;3:338-342.
38. Bush G, Fink M, Petrides G, et al. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand. 1996;93:137-143.
39. Green A. Changes in gamma-aminobutyric acid biochemistry and seizure threshold. Ann N Y Acad Sci. 1986;462:105-119.
40. Sanacora G, Mason G, Rothman D, et al. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry. 2003;160:577-579.
41. Northoff G, Steinke R, Czcervenka C, et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry. 1999;67:445-450.
42. Nisijima K, Ishiguro T. Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndrome. J Psychiatr Res. 1995;3:233-244.
43. Decavel C, van den Pol A. GABA: a dominant neurotransmitter in the hypothalamus. J Comp Neurol. 1990;302:1019-1037.
44. Herman J, Cullinan W. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 1997;20:78-84.
45. Engelmann M, Landgraf R, Wotjak C. The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited. Frontiers Neuroendocrinol. 2004;25:132-149.
46. Gjessing L. Hypothalamic dysfunction in periodic catatonia. J Oslo City Hosp. 1986;36:105-116.
47. Leonhard K. The Classification of Endogenous Psychoses. In: Robins E, ed. New York: Irvington Publications; 1979.
48. Beckmann H, Franzek E, Stöber G. Genetic heterogeneity in catatonic schizophrenia: a family study. Am J Med Genet (Neuropsychiatr Genet). 1996;67:289-300.
49. Pfuhlmann B, Franzek E, Stöber G, et al. On interrater reliability for Leonhard's classification of endogenous psychoses. Psychopathology. 1997;30:100-150.
50. Neumärker K-J. Leonhard and the classification of psychomotor psychoses in childhood and adolescence. Psychopathol. 1990;23:243-252.
51. Stöber G, Haubitz I, Franzek E, et al. Parent-of-origin effect and evidence for differential transmission in periodic catatonia. Psychiatr Genet. 1998;8:213-219.
52. Stöber G, Saar K, Ruschendorf F, et al. Splitting schizophrenia: periodic catatonia susceptibility locus on chromosome 15q15. Am J Hum Genet. 2000;67:1201-1207.
53. Stöber G, Seelow D, Ruschendorf F, et al. Periodic catatonia: confirmation of linkage to chromosome 15 and further evidence for genetic heterogeneity. Hum Genet. 2002;111:323-330.
54. Clarke D. Prader-Willi syndrome and psychoses. Br J Psychiatry. 1993;163:680-684.
55. Abe K, Ohta M. Recurrent brief episodes with psychotic features in adolescence: periodic psychosis of puberty revisited. Br J Psychiatry. 1995;167:507-513.
56. Bartolucci G, Younger J. Tentative classification of neuropsychiatric disturbances in Prader-Willi syndrome. J Intellect Disab Res. 1994;38:621-629.
57. Verhoeven W, Tuinier S. Prader-Willi syndrome: atypical psychoses and motor dysfunctions. Int Rev Neurobiol. 2006;72:119-130.
58. Verhoeven W, Curfs L, Tuinier S. Prader-Willi syndrome and cycloid psychoses. Intellect Disabil Res. 1998;42:455-462.
59. Boer H, Holland A, Whittington J, et al. Psychotic illness in people with Prader-Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet. 2002;12:135-136.
60. Vogels A, Matthijs G, Legius E, et al. Chromosome 15 maternal uniparental disomy and psychosis in Prader-Willi syndrome. J Med Genet. 2003;40:72-73.
61. Cook E, Courchesne R, Cox N, et al. Linkage-disequilibrium mapping of autistic disorders, with 15q11-13 markers. Am J Hum Genet. 1998;62:1077-1083.
62. Chagnon Y. Shared susceptibility region on chromosome 15 between autism and catatonia. Int Rev Neurobiol. 2006;72:165-178.
63. Dhossche D, Song Y, Liu Y-M. Is there a connection between autism, Prader-Willi syndrome, catatonia, and GABA? Int Rev Neurobiol. 2005;71:189-216.
64. Cooper SJ, Scott AI, Whalley LJ. A neuroendocrine view of ECT. Br J Psychiatry. 1990;157:740-743.
65. Fink M, Nemeroff C. A neuroendocrine view of ECT. Convuls Ther. 1989;5:296-304.
66. Swartz CM. Neuroendocrine effects of electroconvulsive therapy (ECT). Psychopharmacol Bull. 1997;33:265-271.
67. Gjessing LR. Effect of thyroxine, pyridoxine, orphenadrine-HCl, resperine and disulfiram in periodic catatonia. Acta Psychiatr Scand. 1967;43:376-384.
68. Carroll B, Goforth H. Medical catatonia. In: Caroff S, Mann S, Francis A, et al, eds. Catatonia. From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Publishing, Inc.; 2004.
69. McDaniel W, Spiegel D. Hyponatremia and abnormal ingestion of water in catatonia. Prim Psychiatry. 2010;17:29-33.
70. Swaab D. Prader-Willi syndrome and the hypothalamus. Acta Pediatr (Supplement). 1997;423:50-54.
71. Swaab D, Purba J, Hofman M. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrinol Metab. 1995;80:573-579.
72. Ebert M, Schmidt D, Thompson T, et al. Elevated gamma-aminobutyric acid (GABA) levels in individuals with either Prader-Willi syndrome or Angelman syndrome. J Neuropsychiatry Clin Neurosci. 1997;9:75-80.
73. Lucignani G, Panzacchi A, Bosio L, et al. GABA-A receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11-C]flumazenil. Neuroimage. 2004;22:22-28.
74. Hegarty A, Merriam AE. Autonomic events in Kleine-Levin syndrome. Am J Psychiatry. 1990;147:951-952.
75. Thompson C, Obrecht R, Franey C, et al. Neuroendocrine rhythms in a patient with the Kleine-Levin syndrome. Br J Psychiatry. 1985;147:440-443.
76. Critchley H. Periodic hypersomnia and megaphagia in adolescent males. Brain. 1962;85:627-656.
77. Dhossche D, Wachtel L. Catatonia is hidden in plain sight among different pediatric disorders: a review article. Pe d Ne urol . 2010;43:307-315.
78. Kinrys P, Logan K. Periodic catatonia in an adolescent [letter]. J Am Acad Child Adolesc Psychiatry. 2001;40:741-742.
79. Johnson J, Lucey P. Encephalitis lethargica: a contemporary cause of catatonic stupor. A report of two cases. Br J Psychiatry. 1987;151: 550-552.
80. Raskin DE, Frank SW. Herpes encephalitis with catatonic stupor. Arch Gen Psychiatry. 1974;31:544-546.
81. Volkow ND, Harper A, Munnisteri D, et al. AIDS and catatonia. J Neurol Neurosurg Psychiatry. 1987;50:104.
82. Durrant W. Catatonia after malaria. Br Med J. 1977;2:893.
83. Breakey WR, Kala AK. Typhoid catatonia responsive to ECT. Br Med J. 1977;2:357-359.
84. Howard K, Lees A. Encephalitis lethargica. A report of four recent cases. Brain. 1987;28:19-33.
85. Ono Y, Manabe Y, Hamakawa Y, et al. Steroid-responsive encephalitis lethargica syndrome with malignant catatonia. Intern Med. 2007;46: 307-310.
86. Cardinal R, Shah D, Edwards C, et al. Psychosis and catatonia as a first presentation of antiphospholipid syndrome. Br J Psychiatry. 2009;195:272.
87. Joseph F, Lammie G, Scolding N. CNS lupus. A study of 41 patients. Neurol. 2007;69:644-654.
88. Kronfol Z, Schlesser M, Tsuang MT. Catatonia and systemic lupus erythematosus. Dis Nerv Syst. 1977;38:729-731.
89. Elia J, Dell M, Friedman D, et al. PANDAS with catatonia: a case-report. Therapeutic response to lorazepam and plasmapheresis. J Am Acad Child Adolesc Psychiatry. 2005;44:1145-1150.
90. Wang H-Y, Huang T-L. Benzodiazepines in catatonia associated with systemic lupus erythematosus. Psychiatr Clin Neurosci. 2006;60: 768-770.
91. Ali S, Welch C, Park L, et al. Encephalitis and catatonia treated with ECT. Cogn Behav Neurol. 2008;21:46-51.
92. Fricchione GL, Kaufman LD, Gruber BL, et al. Electroconvulsive therapy and cyclophosphamide in combination for severe neuropsychiatric lupus with catatonia. Am J Med. 1990;88:442-443.
93. Dalmau J, Gleichman AJ, Hughes EG, et al. AntiYNMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091-1098.
94. Moscato E, Jain A, Peng X, et al. Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies. Eur J Neurosci. 2010 July 14. [Epub ahead of print].
95. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of antiYNMDA receptor encephalitis. J Neurosci. 2010;30:5866-5875.
96. Breese E, Dalmau J, Lennon V, et al. AntiYN-methyl-D-aspartate receptor encephalitis: early treatment is beneficial. Ped Neurol. 2010;42:213-214.
97. Florance N, Davis R, Lam C, et al. AntiYN-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66:11-18.
98. Schimmel M, Bien C, Vincent A, et al. Successful treatment of antiYN-methyl-D-aspartate receptor encephalitis presenting with catatonia. Arch Dis Child. 2009;94:314-316.
99. Sullivan B, Dickerman J. Steroid-associated catatonia: report of a case. Pediatrics. 1979;63:677-679.
100. Fink M, Taylor MA. The many varieties of catatonia. Eur Arch Psychiatry Clin Neurosci. 2001;251(suppl 1):8-13.
101. Croarkin P, Emslie G, Mayes T. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases. J Clin Psychiatry. 2008;69:1157-1165.
102. Ghaziuddin N, Alkhouri I, Champine D, et al. ECT treatment of malignant catatonia/NMS in an adolescent: a useful lesson in delayed diagnosis and treatment. J ECT. 2002;18:95-98.
103. Neuhut R, Lindenmayer J, Silva R. Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a review. J Child Adolesc Psychopharmacol. 2009;19: 415-422.
104. Steingard R, Khan A, Gonzalez A, et al. Neuroleptic malignant syndrome: review of experience with children and adolescents. J Child Adolesc Psychopharmacol. 1992;2:183-198.
105. Ty E, Rothner A. Neuroleptic malignant syndrome in children and adolescents. J Child Neurol. 2001;16:157-163.
106. Rani F, Byrne P, Murray M, et al. Paediatric atypical antipsychotic monitoring safety (PAMS) study: pilot study in children and adolescents in secondary- and tertiary-care settings. Drug Saf. 2009;32:325-333.
107. Fink M, Shorter E, Taylor M. Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull. 2010;36:314-320.
108. Fries E, Hellhammer DH, Hellhammer J. Attenuation of the hypothalamic-pituitary-adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolam. Psychoneuroendocrinology. 2006;31:1278-1288.
109. Mikkelsen JD, Soderman A, Kiss A, et al. Effects of benzodiazepines receptor agonists on the hypothalamic-pituitary-adrenocortical axis. Eur J Pharmacol. 2005;519:223-230.
110. Pivac N, Pericic D. Inhibitory effect of diazepam on the activity of the hypothalamic-pituitary-adrenal axis in female rats. J Neural Transm Gen Sect. 1993;92:173-186.
111. Covelli V, Maffione AB, Nacci C, et al. Stress, neuropsychiatric disorders and immunological effects exerted by benzodiazepines. Immunopharmacol Immunotoxicol. 1998;20:199-209.
112. Thomas P, Rascle C, Mastain B, et al. Test for catatonia with zolpidem. Lancet. 1997;349:702.
113. Zaw F, Bates GDL. Replication of zolpidem test for catatonia in an adolescent. Lancet. 1997;349:1914.
114. Fink M, Taylor M. Electroconvulsive therapy. Evidence and challenges. JAMA. 2007;298:330-332.
115. Mervaala E, Kononen M, Fohr J, et al. SPECT and neuropsychological performance in severe depression treated with ECT. J Affect Disord. 2001;66:47-58.
116. Lipcsey A, Kardos J, Prinz G, et al. Der Effect der electrokonvulsiven Therapie auf den GABA-Spiegel des Liquor cerebrospinalis. Psychiatr Neurol Med Psychol (Leipz). 1986;38:554-555.
117. Pfleiderer B, Michael N, Erfurth A, et al. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatr Res Neuroimaging. 2003;122:185-192.
118. Parent J, Yu T, Leibowitz R, et al. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network plasticity in the adult hippocampus. J Neurosci. 1997;17:3727-3738.
119. Bengzon J, Kokaia Z, Elmer E, et al. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci USA. 1997;94:10432-10437.
120. Masden T, Treschow A, Bengzon J, et al. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry. 2000;47:1043-1049.
121. Madsen T, Yeh D, Valentine G, et al. Electroconvulsive seizure treatment increases cell proliferation in rat frontal cortex. Neuropsychopharmacol. 2005;30:27-34.
122. Fischler B, Bocken R, Schneider I, et al. Immune changes induced by electroconvulsive therapy (ECT). Ann N Y Acad Sci. 1992;650: 326-330.
123. Hestad KA, Tonseth S, Stoen CD, et al. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT. 2003;19:183-188.
124. Kronfol Z, Nair MP, Weinberg V, et al. Acute effects of electroconvulsive therapy on lymphocyte natural killer cell activity in patients with major depression. J Affect Disord. 2002;71:211-215.